Affinity Asset Advisors, LLC - 23 Dec 2024 SCHEDULE 13G Report for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager: Affinity Asset Advisors, LLC
Reporting Manager: Affinity Healthcare Fund, LP
Security: Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: AVTX
Shares outstanding: 10,391,792 shares
Disclosed Ownership: 550,765 shares
Ownership: 5.3%
Form type: SCHEDULE 13G
Filing time: 31 Dec 2024, 16:13:00 UTC
Date of event: 23 Dec 2024
Next filing: 13 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Affinity Healthcare Fund, LP	5.3%	550,765	0	550,765	/s/ Michael Cho	Michael Cho
Affinity Asset Advisors, LLC	5.3%	550,765	0	550,765	/s/ Michael Cho	Michael Cho